Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids
ARTICLE;
CANCER CELL CULTURE;
CONTROLLED STUDY;
CYTOTOXICITY TEST;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GEOMETRY;
HALOGENATION;
HUMAN;
HUMAN CELL;
HYBRID;
MOLECULAR BIOLOGY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
NUCLEAR OVERHAUSER EFFECT;
STATISTICAL SIGNIFICANCE;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
DNA TOPOISOMERASES, TYPE I;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
ISOQUINOLINES;
MAGNETIC RESONANCE SPECTROSCOPY;
MODELS, MOLECULAR;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
Stereoselective oxidation by thionyl chloride leading to the indeno[1,2-c]isoquinoline system
Cushman, M.; Cheng, L. Stereoselective Oxidation by Thionyl Chloride Leading to the Indeno[1,2-c]isoquinoline System. J. Org. Chem. 1978, 43, 3781-3783.
Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison
Kohlhagen, G.; Paull, K.; Cushman, M.; Nagafuji, P.; Pommier, Y. Protein-Linked DNA Strand Breaks Induced by NSC 314622, a Novel Noncamptothecin Topoisomerase I Poison. Mol. Pharmacol. 1998, 54, 50-58.
Mechanism of action of eukaryotic DNA topoisomerases and drugs targeted to the enzyme
Pommier, Y.; Pourquier, P.; Fan, Y.; Strumberg, D. Mechanism of Action of Eukaryotic DNA Topoisomerases and Drugs Targeted to the Enzyme. Biochim. Biophys. Acta 1998, 1400, 83-105.
Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons
Strumberg, D.; Pommier, Y.; Paull, K.; Jayaraman, M.; Nagafuji, P.; Cushman, M. Synthesis of Cytotoxic Indenoisoquinoline Topoisomerase I Poisons. J. Med. Chem. 1999, 42, 446-457.
Synthesis of new indeno[1,2-c]isoquinolines: Cytotoxic non-camptothecin topoisomerase I inhibitors
Cushman, M.; Jayaraman, M.; Vroman, J. A.; Fukunaga, A. K.; Fox, B. M.; Kohlhagen, G.; Strumberg, D.; Pommier, Y. Synthesis of New Indeno[1,2-c]isoquinolines: Cytotoxic Non-Camptothecin Topoisomerase I Inhibitors. J. Med. Chem. 2000, 43, 3688-3698.
Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model
Jayaraman, M.; Fox, B. M.; Hollingshead, M.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Synthesis of New Dihydroindeno[1,2-c]isoquinoline and Indenoisoquinolinium Chloride Topoisomerase I Inhibitors Having High in Vivo Anticancer Activity in the Hollow Fiber Animal Model. J. Med. Chem. 2002, 45, 242-249.
The mechanism of topoisomerase I poisoning by a camptothecin analog
Staker, B. L.; Hjerrild, K.; Feese, M. D.; Behnke, C. A.; Burgin, A. B., Jr.; Stewart, L. The Mechanism of Topoisomerase I Poisoning by a Camptothecin Analog. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 15387-15392.
Studies of phthalazine-5,8-quinone, a ring contraction, and some novel and potentially useful fluorescent phthalimides
Parrick, J.; Ragunathan, R. Studies of Phthalazine-5,8-quinone, A Ring Contraction, and Some Novel and Potentially Useful Fluorescent Phthalimides. J. Chem. Soc., Perkin Trans. 1 1993, 211-216.
Synthesis of phthalideisoquinolines from 3-halopyridines and 3,4-dihydroisoquinolinium salts
Slemon, C. E.; Hellwig, L. C.; Ruder, J.-P.; Hoskins, E. W.; MacLean, D. B. Synthesis of Phthalideisoquinolines from 3-Halopyridines and 3,4-Dihydroisoquinolinium Salts. Can. J. Chem. 1981, 59, 3055-3060.
Modification of the hydroxy lactone ring of camptothecin: Inhibition of mammalian topoisomerase I and biological activity
Hertzberg, R. P.; Caranfa, M. J.; Holden, K. G.; Jakas, D. R.; Gallagher, G.; Mattern, M. R.; Mong, S.-M.; Bartus, J. O.; Johnson, R. K.; Kingsbury, W. D. Modification of the Hydroxy Lactone Ring of Camptothecin: Inhibition of Mammalian Topoisomerase I and Biological Activity. J. Med. Chem. 1989, 32, 715-720.
Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity
Jaxel, C.; Kohn, K. W.; Wani, M. C.; Wall, M. E.; Pommier, Y. Structure-Activity Study of the Actions of Camptothecin Derivatives on Mammalian Topoisomerase I: Evidence for a Specific Receptor Site and a Relation to Antitumor Activity. Cancer Res. 1989, 49, 1465-1469.
Differential effects of camptothecin derivatives on topoisomerase i-mediated DNA structure modification
Wang, X.; Wang, L.-K.; Kingsbury, W. D.; Johnson, R. K.; Hecht, S. M. Differential Effects of Camptothecin Derivatives on Topoisomerase I-Mediated DNA Structure Modification. Biochemistry 1998, 37, 9399-9408.
Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex
Wang, X.; Zhao, X.; Hecht, S. M. Role of the 20-Hydroxyl Group in Camptothecin Binding by the Topoisomerase I-DNA Binary Complex. Biochemistry 1999, 38, 4374-4381.
Enantioselective preparation of β-alkyl-γ-butyrolactones from functionalized ketene dithioacetals
Canan Koch, S. S.; Chamberlin, A. R. Enantioselective Preparation of β-Alkyl-γ-butyrolactones from Functionalized Ketene Dithioacetals. J. Org. Chem. 1993, 58, 2725-2737.
Intramolecular [2 + 2] photocycloadditions of 1-(ω-alkenyl)-2-pyridones possessing an ester group on the olefinic carbon chain
Somekawa, K.; Okuhira, H.; Sendayama, M.; Suishu, T.; Shimo, T. Intramolecular [2 + 2] Photocycloadditions of 1-(ω-Alkenyl)-2-pyridones Possessing an Ester Group on the Olefinic Carbon Chain. J. Org. Chem. 1992, 57, 5708-5712.
Induction of reversible complexes between eukaryotic DNA topoisomerase I DNA-containing oxidative base damages. 7,8-Dihydro-8-oxoguanine and 5-hydroxycytosine
Pourquier, P.; Ueng, L.-M.; Fertala, J.; Wang, D.; Park, H.-J.; Essigmann, J. M.; Bjornsti, M.-A.; Pommier, Y. Induction of Reversible Complexes between Eukaryotic DNA Topoisomerase I and DNA-Containing Oxidative Base Damages. 7,8-Dihydro-8-oxoguanine and 5-Hydroxycytosine. J. Biol. Chem. 1999, 274, 8516-8523.